Quest Diagnostics Inc (NYSE:DGX)
$ 153.02 -0.4 (-0.26%) Market Cap: 17.08 Bil Enterprise Value: 23.40 Bil PE Ratio: 20.57 PB Ratio: 2.52 GF Score: 86/100

Quest Diagnostics Inc at JPMorgan Healthcare Conference Transcript

Jan 11, 2023 / 03:30PM GMT
Release Date Price: $152.84 (+0.20%)
Rachel Marie Vatnsdal Olson
JPMorgan Chase & Co, Research Division - Analyst

Perfect. Good morning, everyone. This is Rachel Vatnsdal with the life science tools and diagnostics team here at JPMorgan. And today, I'm joined by Jim Davis and the rest of the Quest Diagnostics team.

So similar to most of the other sessions that you've been attending, this will be a 40-minute session, the first half being a 20-minute presentation by management, followed by 20 minutes of Q&A. For those of you listening online, feel free to submit a question via the webcast function. Otherwise, for those of you in the room, if you have a question, please raise your hand and we have mic runners throughout the room. With that...

James E. Davis
Quest Diagnostics Incorporated - CEO, President & Director

Thank you. So good morning, everyone, and thanks for getting up early to join us here. And as always, our safe harbor disclosure that I'm sure you've read 30 times through the conference today or yesterday.

So we're here to talk about 4 things today. One,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot